CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Plymouth

Burroughs

Burroughs Offers Image Software that Integrates Check and Cash Deposits into the Teller Line

Burroughs Inc. Thursday announced a software distributor agreement with Sullivan, Ill.-based Jaguar Software Development Inc. to sell and distribute its MirrorImage suite of application modules which can be configured to handle different item processing environments in the financial industry.

WWJ Newsradio 950–07/18/2013

Esperion Therapeutics

Esperion Stock Interest Strong, Underwriters’ Over-Allotment Option Exercised

Esperion Therapeutics Inc. (Nasdaq: ESPR), the Plymouth-based developer of new drugs to lower cholesterol levels in the blood, announced that the underwriters of its recently completed initial public offering have exercised in full their option to purchase an additional 750,000 shares of common stock from Esperion to cover over-allotments.

WWJ Newsradio 950–07/14/2013

Esperion Therapeutics

Esperion Therapeutics Going Public (Again) At $14 A Share

PLYMOUTH — For the second time, a Michigan company called Esperion Therapeutics is selling stock to the public. Esperion Wednesday announced a $14-a-share price for an initial public offering of 5 million shares. Esperion is […]

WWJ Newsradio 950–06/26/2013

Esperion Gets Positive Results From New Study Of Cholesterol Drug

Esperion Therapeutics Inc. Friday announced “positive” results from a Phase 2a clinical study of its product candidate ETC-1002 in patients with high cholesterol and a history of bad reactions to existing statin drugs.

WWJ Newsradio 950–06/09/2013

(Credit: Chris Hondros/Getty Images)

32 New Charter Schools Plan To Open In Michigan

Thirty-two new charter schools that meet “very specific educational needs” are scheduled to open in Michigan this fall.

WWJ Newsradio 950–05/23/2013

Esperion Therapeutics

Esperion Files For $70M IPO

The Plymouth-based cholesterol drug developer Esperion Therapeutics Inc. has filed for an initial public stock offering with the federal Securities and Exchange Commission. Esperion is seeking to raise up to $70 million.

WWJ Newsradio 950–05/15/2013

esperion

Esperion Reports Cholesterol Cut Up To 43% In Diabetics On New Drug

Esperion Therapeutics’ proposed new cholesterol-busting drug cut the level of low-density lipoprotein, the so-called bad choleterol, up to 43 percent in a Phase 2 test of diabetic patients.

WWJ Newsradio 950–05/02/2013

Rofin-Sinar

Rofin-Sinar Profit Falls On Flat Revenue

Rofin-Sinar Technologies Inc., the industrial laser maker with headquarters in Plymouth and in Hamburg, Germany, reported net income of $7.4 million or 26 cents a share in its second fiscal quarter ended March 31, down 6 percent from $8 million or 28 cents a share in the same quarter a year earlier.

WWJ Newsradio 950–05/02/2013

Water Main Break In Plymouth Causes Lane Closures

Authorities in Plymouth are currently working to fix a water main that burst early Tuesday morning.

WWJ Newsradio 950–04/30/2013

Advaita-April 2013

Wayne State Biotech Startup Advaita to Participate In New Michigan I-Corps Program

Advaita, a Plymouth-based biotechnology startup spun out of Wayne State University, is one of 25 companies selected to participate in the new Michigan I-Corps program starting in May.

WWJ Newsradio 950–04/23/2013

more

previous